Everolimus in Patients With Metastatic Renal Cell Carcinoma Following Progression on Prior Bevacizumab Treatment

NCT02056587 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

37

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Renal Cell Carcinoma

Interventions

DRUG: Everolimus

Sponsor

Kidney Cancer Research Bureau